Utility of Pancreas Surface Lobularity as a CT Biomarker for Opportunistic Screening of Type 2 Diabetes

Fuente: arXiv
Saved in:
Bibliographic Details
Main Authors: Mathai, Tejas Sudharshan, Prasad, Anisa V., Wang, Xinya, Balamuralikrishna, Praveen T. S., Zhuang, Yan, Suri, Abhinav, Liu, Jianfei, Pickhardt, Perry J., Summers, Ronald M.
Format: Preprint
Published: 2025
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866911263793086464
author Mathai, Tejas Sudharshan
Prasad, Anisa V.
Wang, Xinya
Balamuralikrishna, Praveen T. S.
Zhuang, Yan
Suri, Abhinav
Liu, Jianfei
Pickhardt, Perry J.
Summers, Ronald M.
author_facet Mathai, Tejas Sudharshan
Prasad, Anisa V.
Wang, Xinya
Balamuralikrishna, Praveen T. S.
Zhuang, Yan
Suri, Abhinav
Liu, Jianfei
Pickhardt, Perry J.
Summers, Ronald M.
contents Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease that affects millions of people worldwide. Early detection is crucial as it can alter pancreas function through morphological changes and increased deposition of ectopic fat, eventually leading to organ damage. While studies have shown an association between T2DM and pancreas volume and fat content, the role of increased pancreatic surface lobularity (PSL) in patients with T2DM has not been fully investigated. In this pilot work, we propose a fully automated approach to delineate the pancreas and other abdominal structures, derive CT imaging biomarkers, and opportunistically screen for T2DM. Four deep learning-based models were used to segment the pancreas in an internal dataset of 584 patients (297 males, 437 non-diabetic, age: 45$\pm$15 years). PSL was automatically detected and it was higher for diabetic patients (p=0.01) at 4.26 $\pm$ 8.32 compared to 3.19 $\pm$ 3.62 for non-diabetic patients. The PancAP model achieved the highest Dice score of 0.79 $\pm$ 0.17 and lowest ASSD error of 1.94 $\pm$ 2.63 mm (p$<$0.05). For predicting T2DM, a multivariate model trained with CT biomarkers attained 0.90 AUC, 66.7\% sensitivity, and 91.9\% specificity. Our results suggest that PSL is useful for T2DM screening and could potentially help predict the early onset of T2DM.
format Preprint
id arxiv_https___arxiv_org_abs_2511_10484
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle Utility of Pancreas Surface Lobularity as a CT Biomarker for Opportunistic Screening of Type 2 Diabetes
Mathai, Tejas Sudharshan
Prasad, Anisa V.
Wang, Xinya
Balamuralikrishna, Praveen T. S.
Zhuang, Yan
Suri, Abhinav
Liu, Jianfei
Pickhardt, Perry J.
Summers, Ronald M.
Computer Vision and Pattern Recognition
Artificial Intelligence
Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease that affects millions of people worldwide. Early detection is crucial as it can alter pancreas function through morphological changes and increased deposition of ectopic fat, eventually leading to organ damage. While studies have shown an association between T2DM and pancreas volume and fat content, the role of increased pancreatic surface lobularity (PSL) in patients with T2DM has not been fully investigated. In this pilot work, we propose a fully automated approach to delineate the pancreas and other abdominal structures, derive CT imaging biomarkers, and opportunistically screen for T2DM. Four deep learning-based models were used to segment the pancreas in an internal dataset of 584 patients (297 males, 437 non-diabetic, age: 45$\pm$15 years). PSL was automatically detected and it was higher for diabetic patients (p=0.01) at 4.26 $\pm$ 8.32 compared to 3.19 $\pm$ 3.62 for non-diabetic patients. The PancAP model achieved the highest Dice score of 0.79 $\pm$ 0.17 and lowest ASSD error of 1.94 $\pm$ 2.63 mm (p$<$0.05). For predicting T2DM, a multivariate model trained with CT biomarkers attained 0.90 AUC, 66.7\% sensitivity, and 91.9\% specificity. Our results suggest that PSL is useful for T2DM screening and could potentially help predict the early onset of T2DM.
title Utility of Pancreas Surface Lobularity as a CT Biomarker for Opportunistic Screening of Type 2 Diabetes
topic Computer Vision and Pattern Recognition
Artificial Intelligence
url https://arxiv.org/abs/2511.10484